- UriFind Assay Facilitates the Management of Urothelial Carcinoma in a Large-Scale Multicenter Prospective CohortBibikova, M.; Wang, H.; Chen, X.; Liu, Z.; Zhou, L.; Fan, J.; Lv, Q.; Wei, Q.; Chen, H.; Xu, T.; Li, L.; Wang, S.; Tan, W.; Xu, A.; Yang, J.; Zhong, J.; Ruan, W.; Chen, Z.; Fan, J.; Huang, J.; Lin, T.Annual Meeting of the Association-for-Molecular-Pathology (AMP), Salt Lake City, UT, 2023-11-14 To 2023-11-18.
- Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancerRoperch Jean Pierre; Grandchamp Bernard; Desgrandchamps Francois; Mongiat Artus Pierre; Ravery Vincent; Ouzaid Idir; Roupret Morgan; Phe Veronique; Ciofu Calin; Tubach Florence; Cussenot Olivier; Incitti RobertoBMC Cancer, 2016, 16: 704.被引 45
- UriFind assay and association with whole course management of urothelial carcinoma in a large multicentric, prospective China cohortChen, Xu; Liu, Zheng; Zhou, Liqun; Fan, Jinhai; Ruan, Weimei; Wang, Hong; Wei, Qiang; Chen, Haige; Xu, Tao; Li, Lei; Wang, Shaogang; Tan, Wanlong; Xu, Abai; Zhong, Jianmei; Li, Xia; Chen, Zhiwei; Bibikova, Marina; Fan, Jian-Bing; Huang, Jian; Lin, TianxinAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
会议论文
DNA methylation assay UriFind? enables non-invasive and convenient detection of upper tract urothelial carcinoma in a large multicentric cohort
23阅读
